These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31168973)

  • 1. Relationship between genetic variation in the α
    Zhu SJ; Wang KR; Zhang XX; Zhu SM
    J Zhejiang Univ Sci B; 2019 Jul; 20(7):598-604. PubMed ID: 31168973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine.
    Kurnik D; Muszkat M; Li C; Sofowora GG; Friedman EA; Scheinin M; Wood AJ; Stein CM
    Circ Cardiovasc Genet; 2011 Apr; 4(2):179-87. PubMed ID: 21325151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery.
    Yağar S; Yavaş S; Karahalil B
    Mol Biol Rep; 2011 Jun; 38(5):3383-9. PubMed ID: 21104443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-2B adrenoceptor polymorphism and peripheral vasoconstriction.
    Talke P; Stapelfeldt C; Lobo E; Brown R; Scheinin M; Snapir A
    Pharmacogenet Genomics; 2005 May; 15(5):357-63. PubMed ID: 15864138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis between the C-1291G polymorphism in the promoter region of the adrenergic alpha2A receptor gene and polydipsia in schizophrenia.
    Yamaguchi W; Shinkai T; Inoue Y; Utsunomiya K; Sakata S; Fukunaka Y; Yamada K; Chen HI; Hwang R; Ohmori O; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):499-502. PubMed ID: 19439247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of alpha-2A adrenergic receptor (ADRA2A) genetic polymorphisms on the depth of sedation of dexmedetomidine: a genetic observational pilot study.
    Choi YJ; Park KH; Park JY; Min WK; Lee YS
    Braz J Anesthesiol; 2022; 72(2):241-246. PubMed ID: 33915198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic and genetic determinants of cardiovascular response to the selective alpha 2-adrenoceptor agonist dexmedetomidine.
    Kurnik D; Muszkat M; Sofowora GG; Friedman EA; Dupont WD; Scheinin M; Wood AJ; Stein CM
    Hypertension; 2008 Feb; 51(2):406-11. PubMed ID: 18071056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels.
    Rosmond R; Bouchard C; Björntorp P
    J Intern Med; 2002 Mar; 251(3):252-7. PubMed ID: 11886485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception of emotion in facial stimuli: The interaction of ADRA2A and COMT genotypes, and sex.
    Tamm G; Kreegipuu K; Harro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():87-95. PubMed ID: 26234518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in the α(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose.
    Ghimire LV; Muszkat M; Sofowora GG; Scheinin M; Wood AJ; Stein CM; Kurnik D
    Pharmacogenet Genomics; 2013 Sep; 23(9):479-86. PubMed ID: 23873118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females.
    Fukutake M; Hishimoto A; Nishiguchi N; Nushida H; Ueno Y; Shirakawa O; Maeda K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1428-33. PubMed ID: 18547701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Association Between Adrenoreceptor Genotype and the Vasoconstriction Response to Dexmedetomidine.
    Friesen RH; Slavov D; Miyamoto SD; John Ing R; LaRiviere WB; Taylor MRG
    Semin Cardiothorac Vasc Anesth; 2017 Dec; 21(4):341-344. PubMed ID: 28482761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.
    Cho SC; Kim BN; Cummins TD; Kim JW; Bellgrove MA
    J Psychopharmacol; 2012 Mar; 26(3):380-9. PubMed ID: 21628343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception.
    Kohli U; Muszkat M; Sofowora GG; Harris PA; Friedman EA; Dupont WD; Scheinin M; Wood AJ; Stein CM; Kurnik D
    Eur J Pain; 2010 Feb; 14(2):154-9. PubMed ID: 19423370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients.
    Gallaway KA; Skaar TC; Biju A; Slaven J; Tillman EM
    Pharmacotherapy; 2022 Jun; 42(6):453-459. PubMed ID: 35429176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco smoking and the ADRA2A C-1291G polymorphism.
    Prestes AP; Marques FZ; Hutz MH; Roman T; Bau CH
    J Neural Transm (Vienna); 2007; 114(11):1503-6. PubMed ID: 17612790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite to alpha2-adrenergic agonists, an imidazoline I1 selective compound does not influence reflex bradycardia in rabbits.
    Sy GY; Bousquet P; Feldman J
    Auton Neurosci; 2006 Jul; 128(1-2):19-24. PubMed ID: 16464646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular reactivity to mental stress is not affected by alpha2-adrenoreceptor activation or inhibition.
    Philippsen C; Hahn M; Schwabe L; Richter S; Drewe J; Schachinger H
    Psychopharmacology (Berl); 2007 Feb; 190(2):181-8. PubMed ID: 17111173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADRA2A polymorphism and smoking in a Turkish population.
    Karahalil B; Coskun E; Emerce E
    Toxicol Ind Health; 2008 Apr; 24(3):171-6. PubMed ID: 18842695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different loading doses of dexmedetomidine on bispectral index under stepwise propofol target-controlled infusion.
    Wang T; Ge S; Xiong W; Zhou P; Cang J; Xue Z
    Pharmacology; 2013; 91(1-2):1-6. PubMed ID: 23095710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.